Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Solberg NT"'
Autor:
Sorokina L; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no.; Department of Chemistry, University of Oslo, Oslo, Norway., Solberg NT; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Koga S; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Rønning SB; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Afseth NK; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Wilson SR; Department of Chemistry, University of Oslo, Oslo, Norway., Rieder A; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no., Wubshet SG; Nofima AS-Norwegian Institute of Food, Fisheries and Aquaculture Research, PB 210, N-1431 Ås, Norway. sileshi.wubshet@nofima.no.
Publikováno v:
Food & function [Food Funct] 2024 Jul 15; Vol. 15 (14), pp. 7364-7374. Date of Electronic Publication: 2024 Jul 15.
Autor:
Pejšková L; Raw Materials and Optimization, Nofima AS, Ås, Norway., Rønning SB; Raw Materials and Optimization, Nofima AS, Ås, Norway., Kent MP; Center for Integrative Genetics, Department of Animal and Aquacultural Sciences, Faculty of Biosciences (BIOVIT), Norwegian University of Life Sciences (NMBU), Ås, Norway., Solberg NT; Raw Materials and Optimization, Nofima AS, Ås, Norway., Høst V; Raw Materials and Optimization, Nofima AS, Ås, Norway., Thu-Hien T; Center for Integrative Genetics, Department of Animal and Aquacultural Sciences, Faculty of Biosciences (BIOVIT), Norwegian University of Life Sciences (NMBU), Ås, Norway., Wold JP; Raw Materials and Optimization, Nofima AS, Ås, Norway., Lunde M; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway., Mosleth E; Raw Materials and Optimization, Nofima AS, Ås, Norway., Pisconti A; Department of Biochemistry and Cell Biology, Stony Brook, NY, United States., Kolset SO; Department of Nutrition, Institute of Basic Medical Science, University of Oslo, Oslo, Norway., Carlson CR; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway., Pedersen ME; Raw Materials and Optimization, Nofima AS, Ås, Norway.
Publikováno v:
Frontiers in physiology [Front Physiol] 2023 Dec 05; Vol. 14, pp. 1301804. Date of Electronic Publication: 2023 Dec 05 (Print Publication: 2023).
Autor:
Tzimorotas D; Nofima AS, Food Safety and Health, Ås, Norway., Solberg NT; Nofima AS, Raw Materials and Process Optimization, Ås, Norway., Andreassen RC; Nofima AS, Raw Materials and Process Optimization, Ås, Norway., Moutsatsou P; Mosa Meat BV, Maastricht, Netherlands., Bodiou V; Mosa Meat BV, Maastricht, Netherlands., Pedersen ME; Nofima AS, Raw Materials and Process Optimization, Ås, Norway., Rønning SB; Nofima AS, Raw Materials and Process Optimization, Ås, Norway.
Publikováno v:
Frontiers in nutrition [Front Nutr] 2023 Aug 07; Vol. 10, pp. 1192365. Date of Electronic Publication: 2023 Aug 07 (Print Publication: 2023).
Autor:
Andreassen RC; Nofima AS, Raw Materials and Optimization, Ås, Norway., Rønning SB; Nofima AS, Raw Materials and Optimization, Ås, Norway., Solberg NT; Nofima AS, Raw Materials and Optimization, Ås, Norway., Grønlien KG; Section for Pharmaceutics and Social Pharmacy, Department of Pharmacy, University of Oslo, Oslo, Norway., Kristoffersen KA; Nofima AS, Raw Materials and Optimization, Ås, Norway., Høst V; Nofima AS, Raw Materials and Optimization, Ås, Norway., Kolset SO; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway., Pedersen ME; Nofima AS, Raw Materials and Optimization, Ås, Norway. Electronic address: mona.pedersen@nofima.no.
Publikováno v:
Biomaterials [Biomaterials] 2022 Jul; Vol. 286, pp. 121602. Date of Electronic Publication: 2022 May 27.
Autor:
Mygland L; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway., Brinch SA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway., Strand MF; School of Health Sciences, Kristiania University College, P.O. Box 1190 Sentrum, 0107 Oslo, Norway., Olsen PA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway., Aizenshtadt A; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway., Lund K; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway., Solberg NT; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway., Lycke M; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway., Thorvaldsen TE; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, 0379 Oslo, Norway., Espada S; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway., Misaghian D; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway., Page CM; Center for Fertility and Health, Norwegian Institute of Public Health, P.O. Box 222 Skøyen, 0213 Oslo, Norway.; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, Norway., Agafonov O; Bioinformatics Core Facility, Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70, 0379 Oslo, Norway., Nygård S; Department of Informatics, University of Oslo, P.O. box 080 Blindern, 0316 Oslo, Norway., Chi NW; Endocrine Service, VA San Diego Healthcare System, 3350 La Jolla Village Dr., San Diego, CA 92161, USA., Lin E; Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Tan J; Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Yu Y; Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Costa M; Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA., Krauss S; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway., Waaler J; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, Oslo 0424, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway.
Publikováno v:
IScience [iScience] 2021 Jul 01; Vol. 24 (7), pp. 102807. Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
Autor:
Waaler J; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway. jo.waaler@rr-research.no.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway. jo.waaler@rr-research.no., Mygland L; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Tveita A; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway., Strand MF; School of Health Sciences, Kristiania University College, P.O. Box 1190, Sentrum, 0107, Oslo, Norway., Solberg NT; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Olsen PA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Aizenshtadt A; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Fauskanger M; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; K. G. Jebsen Centre for B cell malignancies, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway., Lund K; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Brinch SA; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Lycke M; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Dybing E; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway., Nygaard V; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, 0424, Oslo, Norway., Bøe SL; Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379, Oslo, Norway., Heintz KM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, 0424, Oslo, Norway., Hovig E; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, P.O. Box 4953, Nydalen, 0424, Oslo, Norway.; Center of Bioinformatics, Department of Informatics, University of Oslo, P.O. Box 1080, Blindern, 0316, Oslo, Norway., Hammarström C; Department of Pathology, Oslo University Hospital, Rikshospitalet, P.O. box 4950, Nydalen, 0424, Oslo, Norway., Corthay A; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Rikshospitalet, P.O. box 4950, Nydalen, 0424, Oslo, Norway., Krauss S; Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950, Nydalen, 0424, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110, Blindern, 0317, Oslo, Norway.
Publikováno v:
Communications biology [Commun Biol] 2020 Apr 24; Vol. 3 (1), pp. 196. Date of Electronic Publication: 2020 Apr 24.
Autor:
Solberg NT; Unit for Cell Signaling, Department of Immunology and Transfusion Medicine, Oslo University Hospital, 0372 Oslo, Norway. nina.therese.solberg@rr-research.no.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, Norway. nina.therese.solberg@rr-research.no., Melheim M; Unit for Cell Signaling, Department of Immunology and Transfusion Medicine, Oslo University Hospital, 0372 Oslo, Norway. maria.melheim@rr-research.no.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, Norway. maria.melheim@rr-research.no., Strand MF; Department of Health Sciences, Kristiania University College, PB 1190 Sentrum, 0107 Oslo, Norway. martinfrank.strand@kristiania.no., Olsen PA; Unit for Cell Signaling, Department of Immunology and Transfusion Medicine, Oslo University Hospital, 0372 Oslo, Norway. petter.angell.olsen@rr-research.no.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, Norway. petter.angell.olsen@rr-research.no., Krauss S; Unit for Cell Signaling, Department of Immunology and Transfusion Medicine, Oslo University Hospital, 0372 Oslo, Norway. Stefan.krauss@rr-research.no.; Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, Norway. Stefan.krauss@rr-research.no.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Feb 01; Vol. 11 (2). Date of Electronic Publication: 2019 Feb 01.
Autor:
Solberg NT; Department of Microbiology, Section for Cell Signaling, Oslo University Hospital-Rikshospitalet and Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway. Nina.Therese.Solberg@rr-research.no., Waaler J; Department of Microbiology, Section for Cell Signaling, Oslo University Hospital-Rikshospitalet and Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Lund K; Department of Microbiology, Section for Cell Signaling, Oslo University Hospital-Rikshospitalet and Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Mygland L; Department of Microbiology, Section for Cell Signaling, Oslo University Hospital-Rikshospitalet and Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Olsen PA; Department of Microbiology, Section for Cell Signaling, Oslo University Hospital-Rikshospitalet and Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway., Krauss S; Department of Microbiology, Section for Cell Signaling, Oslo University Hospital-Rikshospitalet and Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2018 Mar; Vol. 16 (3), pp. 543-553. Date of Electronic Publication: 2017 Dec 08.
Autor:
Lund K; Unit for Cell Signaling, Institute of Microbiology, Rikshospitalet, 0372, Oslo, Norway. Kaja.Lund@rr-research.no.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112, Blindern, 0317, Oslo, Norway. Kaja.Lund@rr-research.no., Olsen CE; Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, 0379, Oslo, Norway., Wong JJW; Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, 0379, Oslo, Norway., Olsen PA; Unit for Cell Signaling, Institute of Microbiology, Rikshospitalet, 0372, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112, Blindern, 0317, Oslo, Norway., Solberg NT; Unit for Cell Signaling, Institute of Microbiology, Rikshospitalet, 0372, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112, Blindern, 0317, Oslo, Norway., Høgset A; PCI Biotech AS, Ullernchaussèn 64, 0379, Oslo, Norway., Krauss S; Unit for Cell Signaling, Institute of Microbiology, Rikshospitalet, 0372, Oslo, Norway.; Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112, Blindern, 0317, Oslo, Norway., Selbo PK; Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, 0379, Oslo, Norway. selbo@rr-research.no.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2017 Dec 19; Vol. 36 (1), pp. 187. Date of Electronic Publication: 2017 Dec 19.
Autor:
Olsen PA; Unit for Cell Signaling, Cancer Stem Cell Innovation Centre (SFI-CAST), Oslo University Hospital-Rikshospitalet, Oslo, Norway., Solberg NT; Unit for Cell Signaling, Cancer Stem Cell Innovation Centre (SFI-CAST), Oslo University Hospital-Rikshospitalet, Oslo, Norway., Lund K; Unit for Cell Signaling, Cancer Stem Cell Innovation Centre (SFI-CAST), Oslo University Hospital-Rikshospitalet, Oslo, Norway., Vehus T; Department of Chemistry, University of Oslo, Oslo, Norway., Gelazauskaite M; Unit for Cell Signaling, Cancer Stem Cell Innovation Centre (SFI-CAST), Oslo University Hospital-Rikshospitalet, Oslo, Norway., Wilson SR; Department of Chemistry, University of Oslo, Oslo, Norway., Krauss S; Unit for Cell Signaling, Cancer Stem Cell Innovation Centre (SFI-CAST), Oslo University Hospital-Rikshospitalet, Oslo, Norway.
Publikováno v:
PloS one [PLoS One] 2014 Dec 23; Vol. 9 (12), pp. e115496. Date of Electronic Publication: 2014 Dec 23 (Print Publication: 2014).